Computational Analysis of Tumour Heterogeneity

Sammanfattning: Every tumour is unique and characterised by its genetic, epigenetic, phenotypic, and morphological signature. The diversity observed between and within tumours, and over time, is termed tumour heterogeneity. An increased heterogeneity within a tumour correlates with cancer progression, higher resistance rates, and poorer outcome. Heterogeneity between tumours explains aspects of a treatment’s ineffectiveness. Depending on a tumour’s unique signature, common processes like unhindered cell proliferation, invasiveness, or treatment resistance characterise tumour progression. Studying tumour heterogeneity aims to understand cancer causes and evolution, and eventually to improve cancer treatment outcomes. This thesis presents application and development of computational methods to study tumour heterogeneity. Papers I and II concern the in-depth investigation of clinical tissue samples taken from prostate cancer patients. The findings range from spatial expansion of gene expression patterns based on high-resolution data to a gene expression signature of non-responding cancer cells revealed by spatio-temporal analysis. These cells underwent a transition from an epithelial to a mesenchymal phenotype pre-treatment. Papers III and IV present tools to detect fusion transcripts and copy number variations, respectively. Both tools, applicable to high-resolution data, enable the in-depth study of mutations, which are the driving force behind tumour heterogeneity.The results in this thesis demonstrate how the beneficial combination of high-resolution data and computational methods leads to novel insights of tumour heterogeneity.